HYTN Secures Cannabis Drug License, Advancing Pathway for Prescription Cannabinoid-Based
[PRESS RELEASE] – VANCOUVER, British Columbia, July 14, 2025 – HYTN Innovations Inc., a leader in pharmaceutical-grade cannabis manufacturing, announced it has received a cannabis drug license (CDL) from Health Canada. The CDL, issued July 2, 2025, complements HYTN’s existing drug establishment license (DEL) and federally issued cannabis licenses, placing the company among a limited…
HYTN Secures Cannabis Drug License, Advancing Pathway for Prescription Cannabinoid-Based Read More »










